Angiotensin receptor blockers might be protective against hepatic steatosis after liver transplantation

BACKGROUND: Hepatic steatosis is an increasing complication in liver transplant recipients. Currently, there is no pharmacologic therapy for treatment of hepatic steatosis after liver transplantation. The aim of this study was to determine the association between use of angiotensin receptor blockers...

Descripción completa

Detalles Bibliográficos
Autores principales: Eshraghian, Ahad, Taghavi, Alireza, Nikoupour, Hamed, Nikeghbalian, Saman, Malek-Hosseini, Seyed Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184358/
https://www.ncbi.nlm.nih.gov/pubmed/37189076
http://dx.doi.org/10.1186/s12876-023-02781-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184358/
https://www.ncbi.nlm.nih.gov/pubmed/37189076
http://dx.doi.org/10.1186/s12876-023-02781-9

Ejemplares similares